Implantation of Cardio West Total Artificial Heart for Irreversible Acute Myocardial Infarction Shock
DOI:
https://doi.org/10.1532/HSF98.20070706Abstract
Patients who develop cardiogenic shock after acute myocardial infarction have a very high mortality rate despite early reperfusion therapy. Hemodynamic stabilization can often only be achieved by implanting a mechanical circulatory support system. When, in cases representing expansive myocardial impairment without any chance of recovery, pharmacological therapy and the use of percutaneous assist devices have failed, the implantation of a total artificial heart is indicated. We report our first experiences with this extensive and innovative method of managing irreversible cardiogenic shock patients. The CardioWest total artificial heart was implanted in 5 patients (male; mean age, 50 years). All patients were in irreversible cardiogenic shock despite maximum dosages of catecholamines, an intra-aortic balloon pump and/or a femoro-femoral bypass. In all patients early reperfusion therapy was performed. After implantation of the Cardio West system, all dysfunctional organ systems rapidly recovered in all patients. Four of 5 patients underwent successful heart transplantation after a mean support time of 156 days. One patient died because of enterocolic necroses caused by an embolic event after termination of dicumarol therapy. In summary, our first experiences justify this extensive management in young patients who would otherwise have died within a few hours.References
Allen BS, Buckberg GD, Fontan FM, et al. 1993. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion. J Thorac Cardiovasc Surg105:864-84.nAlonso DR, Scheidt S, Post M, Killip T. 1973. Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical pathologic and electrocardiographic correlations. Circulation48:588-96.nArabia FA, Copeland JG, Pavie A, Smith RG. 1999. Implantation technique for the CardioWest Total Artificial Heart. Ann Thorac Surg68: 698-704.nBengtson JR, Kaplan AJ, Pieper KS, et al. 1992. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol20:1482-9.nBerger PB, Holmes DR Jr, Stebbins AL, Bates EF, Califf RM, Topol EJ. 1997. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial. An observational study. Circulation96:122-7.nBeyersdorf F, Sarai K, Wendt T, Eckel L, Schneider M, Kubitzky W. 1990. Prolonged abnormalities of LV regional wall motion after reperfusion of patients with preoperative cardiogenic shock. Thorac Cardiovasc Surg38:165-74.nChen JM, DeRose JJ, Slater JP, et al. 1999. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol33:1903-8.nCopeland JG, Pavie A, Duveau D, et al. 1996. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993-1995. J Heart Lung Transplant15:94-9.nGISSI-2 The International Study Group. 1990. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet336:71-5.nGoldberg RS, Gare JM, Alpert JS, et al. 1997. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from communitywide perspective, 1975-1988. N Engl J Med325:1117-22.nGrines CL, Topol EJ, Califf RM, et al. 1989. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. Circulation80:245-53.nGruppo Italiano per lo Studio della Streptochinasi nell Ínfarto Miocardio (GISSI). 1986. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet1:397-402.nGunnar RM. 1988. Cardiogenic shock complicating myocardial infarction. Circulation78:1508-10.nHarnarayan C, Bennett MA, Pentecost BL, Brewer DB. 1970. Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J32:728-32.nHill JD, Farrar DJ, Hershon JJ, et al. 1986. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med314:626-8.nHolmes DR Jr, Bates ER, Kleiman NS, et al. 1995. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 trial experience. J Am Coll Cardiol3:668-74.nFarrar DJ, Lawson JH, Litwak P, Cederwall G. 1990. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant9:415-23.nKern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. 1993. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation87:500-11.nKörfer R, El-Banayosy A, Posival H, et al. 1995. Mechanical circulatory support: the Bad Oeynhausen experience. Ann Thorac Surg59:56-63.nLee L, Erbel R, Brown TM, Laufer N, Meyer J, O'Neill WW. 1991. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long term survival. J Am Coll Cardiol17:599-603.nMoosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S. 1992. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol19:907-14.nMoritz A, Wolner E. 1993. Circulatory support with shock due to acute myocardial infarction. Ann Thorac Surg55:238-44.nMueller HS. 1994. Role of intra-aortic counterpulsation in cardiogenic shock and acute myocardial infarction. Cardiology84:168-74.nNoda H, Takano H, Taenaka Y, et al. 1989. Treatment of acute myocardial infarction with cardiogenic shock using left ventricular assist device. Int J Artif Organs12:175-9.nPage DL, Caulfield JB, Kastor JA, DeSanctis RW, Sanders CA. 1971. Myocardial changes associated with cardiogenic shock. N Engl J Med285:133-7.nPark JP, Nguyen DQ, Bank AJ, Ormaza S, Bolman RM 3rd. 2000. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg69:1146-51.nRaithel SC, Swartz MT, Braun PR, et al. 1989. Experience with an emergency resuscitation system. ASAIO Trans35:475-7.nReedy JE, Swartz MT, Raithel SC, Szukalski EA, Pennington DG. 1990. Mechanical cardiopulmonary support for refractory cardiogenic shock. Heart Lung19:514-23.nReichman RT, Joyo CI, Dembitzky WP, et al. 1990. Improved patient survival after cardiac arrest using a cardiopulmonary support system. Ann Thorac Surg49:101-5.nReiß N, Posival H, El-Banayosy A, Schröfel H, Minami K, Körfer R. 1995. Einsatz verschiedener mechanischer Kreislaufunterst - tzungssysteme in der Therapie des kardiogenen Schocks nach akutem Myokardinfarkt. Z Kardiol84(suppl 1):20.nVogt A, Neuhaus KL. 1999. Therapie des akuten Myokardinfarkts—Primäre PTCA oder Thrombolyse? Herz24:363-8.nZeymer U, Reissig M, Neuhaus KL. 1993. Einsatz einer perkutan anschließbaren Herz-Lungen-Maschine unter Reanimationsbedingungen im kardiogenen Schock bei akutem Herzinfarkt. Dtsch Med Wochenschr118:1755-8.nZumbro GL, Kitchens WR, Shearer G, Harville G, Bailey L, Galloway RF. 1987. Mechanical assistance for cardiogenic shock following cardiac surgery, myocardial infarction and cardiac transplantation. Ann Thorac Surg44:11-3.n
